BCa is the first cancer model system in which HYAL-1 was found to be a molecular determinant of tumor growth, invasion, and angiogenesis and also as a diagnostic and prognostic marker [2, 7, 11, 12, 14, 15, 17, 37]. This evidence concerns the gene HYAL1 and neoplasm.